BIRC5 and neoplasm: Interestingly, a recent animal study reported that expression of survivin in residual tumor tissues, taken as a surrogate marker of chemoresistance, began increasing within 6 h of surgery, peaked at post-operative day 2, and decreased to baseline levels by post-operative day 7 [29].